Cargando…

L1 cell adhesion molecule may be a protective molecule for atrial fibrillation in patients with valvular heart disease

BACKGROUND: Atrial fibrillation (AF) is the most prevalent sustained arrhythmia. L1 cell adhesion molecule (L1CAM) served as a crucial regulator of signaling pathways. This research sought to examine the clinical value and functions of soluble L1CAM in the serum of AF patients. METHODS: In total, 11...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dayu, Hu, Bo, Xu, Guangtao, Wei, Ruibin, Liu, Zhen, Wu, Huajun, Xu, Long, Huang, Suiqing, Hou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248256/ https://www.ncbi.nlm.nih.gov/pubmed/37303506 http://dx.doi.org/10.1016/j.heliyon.2023.e16831

Ejemplares similares

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension
por: Wang, Dayu, et al.
Publicado: (2022)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
por: Zhu, Xiyu, et al.
Publicado: (2020)

Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging
por: Hou, Jie, et al.
Publicado: (2022)

Intracellular lactate signaling cascade in atrial remodeling of mitral valvular patients with atrial fibrillation
por: Xu, Jing, et al.
Publicado: (2013)

Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation
por: Scarsoglio, Stefania, et al.
Publicado: (2016)

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu, Yaowu, et al.
Publicado: (2021)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya
por: Temu, Tecla M., et al.
Publicado: (2017)

Remodeling of Ion Channel Expression in Patients with Chronic Atrial Fibrillation and Mitral Valvular Heart Disease
por: Oh, Seil, et al.
Publicado: (2010)

Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery
por: Amr, Yasser Mohamed, et al.
Publicado: (2010)

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure
por: Martinez, Brandon K., et al.
Publicado: (2018)

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
por: Amin, Alpesh, et al.
Publicado: (2019)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
por: Moon, Inki, et al.
Publicado: (2019)

Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
por: Ioannou, Adam, et al.
Publicado: (2017)

Causes of death of patients with non-valvular atrial fibrillation in Asians
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
por: Al-Najar, Mahasen, et al.
Publicado: (2023)

Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2021)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
por: Dhungana, Sahadeb Prasad, et al.
Publicado: (2020)

Reduced Angiopoietin Factor 2 Levels Are Correlated with Better Cardiac Function and Prognosis in Valvular Heart Disease
por: Hou, Jian, et al.
Publicado: (2023)

The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2019)

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and Diabetes
por: Zhao, Yong, et al.
Publicado: (2016)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
por: He, Qiyu, et al.
Publicado: (2019)

Serum miR-222 is independently associated with atrial fibrillation in patients with degenerative valvular heart disease
por: Zhou, Hualan, et al.
Publicado: (2021)

Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
por: Gao, Jie, et al.
Publicado: (2022)

Predictive value of nutritional indices for left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
por: Kim, Chi Kyung, et al.
Publicado: (2013)

Risk Stratification and Anticoagulation in Low-risk Non-valvular Atrial Fibrillation
por: Arya, Arash
Publicado: (2013)

Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
por: Kocis, Paul T., et al.
Publicado: (2016)

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
por: Wu, Jia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6b5sj7q8v4k4bl9d8a1djvvp5s